450 related articles for article (PubMed ID: 25398989)
1. Vasculopathy and pulmonary hypertension in sickle cell disease.
Potoka KP; Gladwin MT
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
[TBL] [Abstract][Full Text] [Related]
2. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
3. Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato GJ; Steinberg MH; Gladwin MT
J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
[TBL] [Abstract][Full Text] [Related]
4. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
Kato GJ; Gladwin MT
JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
[TBL] [Abstract][Full Text] [Related]
5. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell disease, vasculopathy, and therapeutics.
Kassim AA; DeBaun MR
Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
Akinsheye I; Klings ES
J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
[TBL] [Abstract][Full Text] [Related]
9. Vascular pathophysiology of sickle cell disease.
Connes P; Renoux C; Joly P; Nader E
Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.
Gordeuk VR; Castro OL; Machado RF
Blood; 2016 Feb; 127(7):820-8. PubMed ID: 26758918
[TBL] [Abstract][Full Text] [Related]
11. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
12. Vascular complications of sickle cell disease.
Usmani A; Machado RF
Clin Hemorheol Microcirc; 2018; 68(2-3):205-221. PubMed ID: 29614633
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Wood KC; Granger DN
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
Kato GJ; McGowan V; Machado RF; Little JA; Taylor J; Morris CR; Nichols JS; Wang X; Poljakovic M; Morris SM; Gladwin MT
Blood; 2006 Mar; 107(6):2279-85. PubMed ID: 16291595
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.
Villagra J; Shiva S; Hunter LA; Machado RF; Gladwin MT; Kato GJ
Blood; 2007 Sep; 110(6):2166-72. PubMed ID: 17536019
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Sickle Cell Disease.
Sundd P; Gladwin MT; Novelli EM
Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis-associated pulmonary hypertension in thalassemia.
Morris CR; Kuypers FA; Kato GJ; Lavrisha L; Larkin S; Singer T; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():481-5. PubMed ID: 16339702
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular complications in patients with sickle cell disease.
Gladwin MT
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):423-430. PubMed ID: 29222288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]